Hydroxychloroquine for prophylaxis of COVID-19 in health workers: A randomized clinical trial보건 종사자의 Covid-19의 예방에 대한 하이드 록시 클로로 퀴인 : 무작위 임상 시험Randomized Controlled Trial Published on 2022-02-092022-09-10 Journal: PLoS ONE [Category] COVID19(2023년), MERS, SARS, 임상, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 assigned baseline clinical trial Complete coronavirus coronavirus disease COVID-19 effect size Effectiveness Efficacy and safety evaluate failure HCQ Health Health care Health care worker health care workers Health personnel high risk hospitalized patient hospitalized patients Hydroxychloroquine lack negative RT-PCR outcome Patient Placebo placebo group placebo-controlled Prophylaxis Randomized randomized clinical trial refusal reported respiratory Result Sample size SARS-CoV-2 SARS-COV-2 infection SARS-CoV2 severe acute respiratory syndrome Coronavirus severe COVID-19 severe COVID-19 patients single center statistically significant subject symptomatic infection symptomatic SARS-CoV-2 infection The effect size the placebo group Trial with COVID-19 [DOI] 10.1371/journal.pone.0261980 PMC 바로가기 [Article Type] Randomized Controlled Trial
Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario Research Published on 2022-02-072022-10-05 Journal: Nature Microbiology [Category] COVID19(2023년), SARS, 변종, 임상, [키워드] AstraZeneca B.1.1.7 B.1.351 B.1.617.2 benefit Beta Canada caused ChAdOx1 combinations COVID-19 hospitalization COVID-19 vaccine death Delta disease severity dose Effectiveness estimate Gamma greater Hospitalization individual Moderna mRNA-1273 of BNT162b2 Older outcome P.1 Pfizer-BioNTech receiving SARS-CoV-2 SARS-CoV-2 variant second dose symptomatic symptomatic infection symptomatic SARS-CoV-2 infection tested Vaccine variants of concern VoC [DOI] 10.1038/s41564-021-01053-0 [Article Type] Research
COVID-19 measures in Belgium: how perception and adherence of the general population differ between time periodsResearch Published on 2022-02-072022-10-28 Journal: BMC Public Health [Category] COVID-19, COVID19(2023년), Fulltext, MERS, SARS, [키워드] adherence age Belgium COVID-19 COVID-19 cases COVID-19 pandemic Factor fatigue French Gender General population Infection prevention and control measures infection risk Linear regression male measure Measures offer pandemic parent Participants participated population survey Protective questionnaire reported Result risk factor Risk factors risk of infection Risk perception score severity sustained symptomatic infection [DOI] 10.1186/s12889-022-12654-7 PMC 바로가기 [Article Type] Research
Long-term physical, mental and social health effects of COVID-19 in the pediatric population: a scoping reviewReview Article Published on 2022-02-032022-10-28 Journal: World Journal of Pediatrics [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] acute respiratory syndrome addition adolescents Brain children conducted coronavirus coronavirus disease Coronavirus disease 2019 (COVID-19) Course COVID-19 COVID-19 case COVID-19 illness determine Direct Effect English exacerbate fatigue Health Impact inclusion criteria Infection initial Long-COVID symptoms Longitudinal studies majority Mental moderate MOST outcomes pandemic pediatric physical Physical symptom physiological Population populations problem Psychological question raise reported Result Science social environment Symptom symptomatic infection Symptoms Web of Science [DOI] 10.1007/s12519-022-00515-7 PMC 바로가기 [Article Type] Review Article
Assessment of the Field Utility of a Rapid Point-of-Care Test for SARS-CoV-2 Antibodies in a Household Cohort가정용 코호트에서 SARS-COV-2 항체에 대한 빠른 요약 테스트의 현장 유용성 평가Article Published on 2022-01-242022-09-10 Journal: The American Journal of Tropical Medicine and Hygi [Category] MERS, SARS, 진단, 치료기술, [키워드] 95% CI 95% confidence interval Antibody test antibody tests assessment asymptomatic infection cohort study convalescence COVID-19 detect ELISA enrolled field household IgM/IgG Infection Interpretation natural infection offer participant POC Rapid rapid antibody test Rapid antibody tests retained SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody sensitivity Seroconversion serostatus specificity symptom onset symptomatic infection symptomatic infections Test tested vaccination variety [DOI] 10.4269/ajtmh.21-0592 PMC 바로가기 [Article Type] Article
Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection증상이 있는 SARS-CoV-2 감염에 대한 mRNA-1273 및 BNT162b2의 비교 효과Article Published on 2022-01-142022-09-11 Journal: Med (New York, N.Y.) [Category] SARS, 변종, 진단, 치료제, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age BNT162b2 Breakthrough infection breakthrough infections Case-control Comorbidities Comparative comparative effectiveness coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 demographic characteristics effective Effectiveness Ethnicity Geography Health highlight imperative Infection Mayo Clinic MONITOR mRNA mRNA vaccines mRNA-1273 Odds ratio PROTECT respiratory Safe SARS-CoV-2 Sex study duration symptomatic symptomatic infection symptomatic SARS-CoV-2 infection vaccination Vaccine Vaccines variant was reduced [DOI] 10.1016/j.medj.2021.12.002 PMC 바로가기 [Article Type] Article
Symptomatic SARS-CoV-2 Infection with Ageusia after Two mRNA Vaccine DosesCase Report Published on 2022-01-132022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, SARS, [키워드] adopted Ageusia BNT162b2 Pfizer vaccine Case report coronavirus COVID-19 COVID-19 pandemic dental practitioner determine Diagnosis Efficacy healthcare worker immunization individual Infection investigated Loss marker mRNA nasal congestion Patient performed Personal protective equipment postvaccination prevented preventive measure protocol raise reported symptoms SARS-CoV-2 Spread Swab symptomatic infection symptomatic infections symptomatic SARS-CoV-2 infection Trial vaccination Vaccine Viral genome sequencing [DOI] 10.3390/ijerph19020886 PMC 바로가기 [Article Type] Case Report
The incidence of COVID-19 infection following emergency use authorization of BBIBP-CORV inactivated vaccine in frontline workers in the United Arab Emirates응급 사용 후 Covid-19 감염의 발생률은 아랍 에미리트의 최전선 근로자에서 BBIBP-CORV 불활성 백신의 승인Article Published on 2022-01-112022-09-10 Journal: Scientific Reports [Category] SARS, 임상, 진단, 치료기술, [키워드] 95% CI BBIBP-CorV clinical trial conducted COVID-19 COVID-19 infection COVID-19 infections dose Emergency use authorization Epidemiology EUA first dose inactivated Inactivated vaccine incidence of COVID-19 incidence rate individual Infection inoculation Medical research Outcomes research PCR positive phase Phase III clinical trials prospective cohort study reported risk SARS CoV second dose Serious Adverse Event Serious Adverse Events seroconversion rate severe disease suffered symptomatic symptomatic infection the vaccine United Arab Emirate vaccinated individual vaccinated individuals vaccination Vaccine [DOI] 10.1038/s41598-021-04244-1 PMC 바로가기 [Article Type] Article
Markers for severe disease and long-term sequelae in pediatric patients with severe acute respiratory syndrome coronavirus 2 infection중증 급성 호흡기 증후군 코로나바이러스 2 감염 소아 환자의 중증 질환 및 장기 후유증 표지자Article Published on 2022-01-012022-09-11 Journal: Pediatrics international : official journal of the [Category] SARS, 바이오마커, [키워드] abnormality acute COVID-19 acute disease acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adolescence Adults Affect age age distribution bimodal Birth caused Chain Reaction Chest Chest radiograph children chronic chronic disease clinical marker clinical markers Comorbidity Complication coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 defined demographic determine disease Fewer patients infancy Infection Lung disease marker morbidity and mortality MOST obesity oxygen parameter Patient PCR pediatric pediatric COVID-19 Pediatric patient polymerase chain polymerase chain reaction positive positive pressure positive pressure ventilation pressure ventilation Research respiratory retrospective review SARS-CoV-2 SARS-CoV2 severe acute respiratory syndrome Coronavirus severe COVID-19 severe disease significantly supplemental oxygen Symptom symptomatic infection tertiary care hospital the disease [DOI] 10.1111/ped.15177 PMC 바로가기 [Article Type] Article
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysisSARS-CoV-2 변이체에 대한 보호 예측 인자로서의 중화 항체 역가 및 부스팅의 영향: 메타 분석Meta-Analysis Published on 2022-01-012022-09-11 Journal: The Lancet. Microbe [Category] MERS, SARS, 변종, 진단, [키워드] Alpha analysed Analysis Antibody titre Beta booster vaccination correlated decrease decreases Effect Efficacy elicited Future In-vitro infected individual Infection infection with SARS-CoV-2 Medical Research Council medium Meta-analysis neutralisation neutralisation titre Neutralising activity not significantly different outcome predict predicted Predictive predictor reduced remained robust SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants serum Severe infection shown statistical model suggested symptomatic infection titre vaccination vaccination schedule Vaccine vaccine efficacy vaccine response vaccine responses Vaccines variant variants variants of concern virus virus infection waning immunity [DOI] 10.1016/S2666-5247(21)00267-6 PMC 바로가기 [Article Type] Meta-Analysis